Advanced Filters
noise
Found 65,199 clinical trials
H Hugh M Herr, PhD

AMI Construction in Lower Extremity Residual Limbs

This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy

18 - 65 years of age All Phase N/A
J Julin Shuxian Wong

The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy

Medical termination of pregnancy (mTOP) generally involves using either a combined regimen consisting of mifepristone and misoprostol, or a misoprostol-only regimen. Complete abortion rates of first trimester mTOP with the use of misoprostol-only regimen varies between 74-88%. With the addition of mifepristone as pre-treatment drug, this improves success rates to …

21 years of age Female Phase 4
S Shaimaa eldesouky, PhD

Comparative Evaluation of Eggshell Powder in Primary Teeth Pulpotomy

To assess & compare clinical & radiographic effects of Eggshell Powder, Biodentine and MTA as pulpotomy agents in primary teeth.

4 - 7 years of age All Phase N/A
D Domingo Hernández, MD,PhD

Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

Background: Subclinical inflammation, including borderline lesions (BL), is very common (30-40%) after kidney transplantation (KT), even in low immunological risk patients, and can lead to interstitial fibrosis/tubular atrophy (IFTA) and worsening of renal function with graft loss. Few controlled studies have analyzed the therapeutic benefit of these BL on renal …

18 years of age All Phase 4

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

The purpose of this study is three-fold. First, researchers will assess whether subjects who have clinically abnormal reactions to sunlight (photosensitivity) have increased levels of microvesicle particles (MVP) following ultraviolet B (UVB) treatment to localized area of skin. Second, researchers will assess if topical application of the medicine imipramine will …

18 - 50 years of age All Phase 1
O Olu Owoeye, PhD

MAP for Coaches: Translating Sports Injury Prevention Knowledge to Youth Sport Coaches

The goal of this clinical trial is to test the effectiveness of the MAP for Coaches, a web-based Musculoskeletal Athletic injury Prevention training course, in youth sport coaches. The main question it aims to answer are: Is the MAP for Coaches effective in increasing coaches' sport-specific knowledge of musculoskeletal injuries …

18 years of age All Phase N/A
C Cecilia Bergeria, PhD

Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants

The purpose of the present study is to examine the pharmacokinetics and pharmacodynamics of cannabigerol (CBG; CHI-914), a naturally occurring chemical constituent of the cannabis plant formulated for oral consumption, in healthy adults. The study will utilize a within-subjects, placebo-controlled, double-blind, ascending-dose design.Upon enrollment, participants will complete 5 oral dosing …

18 - 55 years of age All Phase 1
L Lorren Whitaker, PhD

Internet Assisted Career-Oriented Soft-skills Training for Transition Age Youth With Mental Health Conditions

The purpose of this study is to evaluate the effectiveness of an internet- assisted Career-Oriented Work-Related Soft-skills Training (iCareer) intervention, infused with cognitive behavioral therapy, targeting individuals ages 16-24 with mental health conditions, to improve employment outcomes. The overall objective is to help transition-age youth (TAY) with psychiatric disabilities achieve …

16 - 24 years of age All Phase N/A
I Ioannis Dimitroulis, MD

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely, the "Score of PACS progression reversal"

18 years of age All Phase 2/3
D DUMURGIER Julien, MD, PhD

Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

Donepezil, as well as the other symptomatic drugs of Alzheimer's disease, is not any more reimbursed by the French healthcare system, due to a controversy about its efficiency. French health authorities currently preconize a non-rug approach based on cognitive remediation or stimulation. The aim of this study is to compare …

50 years of age All Phase 3

Simplify language using AI